» Articles » PMID: 24909163

Epigenetics in Radiation-induced Fibrosis

Overview
Journal Oncogene
Date 2014 Jun 10
PMID 24909163
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy is a major cancer treatment option but dose-limiting side effects such as late-onset fibrosis in the irradiated tissue severely impair quality of life in cancer survivors. Efforts to explain radiation-induced fibrosis, for example, by genetic variation remained largely inconclusive. Recently published molecular analyses on radiation response and fibrogenesis showed a prominent role of epigenetic gene regulation. This review summarizes the current knowledge on epigenetic modifications in fibrotic disease and radiation response, and it points out the important role for epigenetic mechanisms such as DNA methylation, microRNAs and histone modifications in the development of this disease. The synopsis illustrates the complexity of radiation-induced fibrosis and reveals the need for investigations to further unravel its molecular mechanisms. Importantly, epigenetic changes are long-term determinants of gene expression and can therefore support those mechanisms that induce and perpetuate fibrogenesis even in the absence of the initial damaging stimulus. Future work must comprise the interconnection of acute radiation response and long-lasting epigenetic effects in order to assess their role in late-onset radiation fibrosis. An improved understanding of the underlying biology is fundamental to better comprehend the origin of this disease and to improve both preventive and therapeutic strategies.

Citing Articles

The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review.

Cheng Y, Shang Y, Zhang S, Fan S Cancer Biol Med. 2025; 21(12.

PMID: 39831771 PMC: 11745087. DOI: 10.20892/j.issn.2095-3941.2024.0415.


Epigenetic memory of radiotherapy in dermal fibroblasts impairs wound repair capacity in cancer survivors.

Bian X, Piipponen M, Liu Z, Luo L, Geara J, Chen Y Nat Commun. 2024; 15(1):9286.

PMID: 39468077 PMC: 11519383. DOI: 10.1038/s41467-024-53295-1.


Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis.

Wang Y, Chen S, Bao S, Yao L, Wen Z, Xu L Front Immunol. 2024; 15:1338922.

PMID: 38426100 PMC: 10902513. DOI: 10.3389/fimmu.2024.1338922.


TLR4-A Pertinent Player in Radiation-Induced Heart Disease?.

Gawali B, Sridharan V, Krager K, Boerma M, Pawar S Genes (Basel). 2023; 14(5).

PMID: 37239362 PMC: 10218711. DOI: 10.3390/genes14051002.


The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.

Bai J, Wu B, Zhao S, Wang G, Su S, Lu B J Inflamm Res. 2022; 15:6357-6371.

PMID: 36424918 PMC: 9680686. DOI: 10.2147/JIR.S384279.


References
1.
Khan S, Guevara C, Fujii G, Parry D . p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts. Oncogene. 2004; 23(36):6040-6. DOI: 10.1038/sj.onc.1207824. View

2.
Li C, Wilson P, Levine E, Barber J, Stewart A, Kumar S . TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer. 1999; 84(2):155-9. DOI: 10.1002/(sici)1097-0215(19990420)84:2<155::aid-ijc11>3.0.co;2-s. View

3.
Zhao W, Robbins M . Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem. 2009; 16(2):130-43. DOI: 10.2174/092986709787002790. View

4.
Andreassen C, Alsner J . Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 2009; 92(3):299-309. DOI: 10.1016/j.radonc.2009.06.015. View

5.
Zhao L, Lu X, Cao Y . MicroRNA and signal transduction pathways in tumor radiation response. Cell Signal. 2013; 25(7):1625-34. PMC: 3713775. DOI: 10.1016/j.cellsig.2013.04.004. View